Solid Biosciences Inc.
SLDB
$9.54
-$0.39-3.93%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -54.80M | -56.74M | -49.79M | -45.78M | -39.48M |
| Total Depreciation and Amortization | 391.00K | 395.00K | 467.00K | 376.00K | 386.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.76M | 6.81M | 9.01M | 4.76M | 4.22M |
| Change in Net Operating Assets | -3.94M | 2.31M | -13.25M | 7.17M | -2.54M |
| Cash from Operations | -52.59M | -47.23M | -53.56M | -33.47M | -37.41M |
| Capital Expenditure | -150.00K | -165.00K | -565.00K | -85.00K | -377.00K |
| Sale of Property, Plant, and Equipment | -- | -- | 85.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -133.44M | 44.92M | 47.49M | -45.19M | -32.36M |
| Cash from Investing | -133.59M | 44.76M | 47.01M | -45.27M | -32.73M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -203.00K | -243.00K | -142.00K |
| Issuance of Common Stock | 49.23M | 251.92M | 5.35M | 1.42M | 202.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -754.00K | -12.89M | 0.00 | 0.00 | -1.66M |
| Cash from Financing | 48.47M | 239.03M | 5.14M | 1.18M | -1.60M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -137.71M | 236.56M | -1.40M | -77.57M | -71.75M |